Buscar resultados de ensayos clínicos
Hereditary Angioedema Types I and II - 7 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condición: Hereditary Angioedema Types I and II Fecha: 2014-12-10 Intervenciones: Biological: C1-esterase inhibitor |
Completed |
Nombre del estudio: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condición: Hereditary Angioedema Types I and II Fecha: 2013-07-29 Intervenciones:
|
Recruiting |
Nombre del estudio: Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema Condición: Hereditary Angioedema Types I and II Fecha: 2013-04-04 Intervenciones: Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc |
Completed |
Nombre del estudio: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor Condición: Hereditary Angioedema Types I and II Fecha: 2012-12-24 Intervenciones:
|
Completed |
Nombre del estudio: A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route Condición: Hereditary Angioedema Types I and II Fecha: 2012-04-10 Intervenciones:
|
Completed |
Nombre del estudio: Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert Condición: Hereditary Angioedema Types I and II Fecha: 2011-11-07 Intervenciones: Biological: Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection |
Completed |
Nombre del estudio: Kinetics, Efficacy and Safety of C1-Esteraseremmer-N Condición:
Fecha: 2005-07-04 Intervenciones: Drug: C1 inhibitor concentrate |